A5008788846- COVID-19 Clinical Research Studies
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Long-Term Effects of COVID-19
- Atrial Fibrillation Management and Outcomes
- Cardiac Imaging and Diagnostics
- Diabetes Treatment and Management
- Liver Disease and Transplantation
- Venous Thromboembolism Diagnosis and Management
- Pulmonary Hypertension Research and Treatments
- Potassium and Related Disorders
- Liver Disease Diagnosis and Treatment
- Acute Myocardial Infarction Research
- Cardiac pacing and defibrillation studies
- COVID-19 and healthcare impacts
- Acute Kidney Injury Research
- Electrolyte and hormonal disorders
- Cardiac Valve Diseases and Treatments
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Cardiac Structural Anomalies and Repair
- Cardiac Arrest and Resuscitation
- Intensive Care Unit Cognitive Disorders
- Cardiovascular Issues in Pregnancy
- Blood Pressure and Hypertension Studies
- Metabolism, Diabetes, and Cancer
Brigham and Women's Hospital
2023-2025
Harvard University
2024-2025
Einstein Medical Center Philadelphia
2017-2024
UConn Health
2024
Jefferson Hospital
2024
Thomas Jefferson University
2020-2024
Universidad Autónoma de Nuevo León
2024
Albert Einstein College of Medicine
2023
Binus University
2023
University of Illinois Chicago
2023
The coronavirus disease 2019 (COVID-19) pandemic has affected almost 2.5 million people worldwide with 170,000 deaths reported to date. So far, there is scarce evidence for the current treatment options available COVID-19. Vitamin C previously been used of severe sepsis and septic shock. We reviewed feasibility using vitamin in setting COVID-19 a series patients.
Bacterial coinfection is associated with poor outcomes in patients viral pneumonia, but data on its role the mortality of coronavirus disease 2019 (COVID-19) limited. This a single-center retrospective analysis 242 confirmed COVID-19 admitted to both intensive care and non-intensive settings. was determined by presence characteristic clinical features positive culture results. Multivariable logistic regression used analyze association concomitant bacterial infection inpatient death after...
There is no current standardized approach to anticoagulation in patients with Coronavirus Disease 2019 (COVID-19) while potential bleeding risks remain. Our study characterizes the patterns of use COVID-19 and risk related bleeding.
<b><i>Introduction:</i></b> Emerging data have described poor clinical outcomes from infection with the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) among African American patients and those underserved socioeconomic groups. We sought to describe characteristics of kidney injury (AKI) in this special population. <b><i>Methods:</i></b> This is a retrospective study conducted an area predominance disease 2019 (COVID-19)....
Background Current guidelines suggest the use of loop diuretics as preferred agent for decongestion in patients with heart failure. However, there is no clear evidence to superiority one diuretic over other. The understanding pharmacokinetic and pharmacodynamic torsemide furosemide has generated hypothesis that these features could result better clinical outcomes.
BACKGROUND: Several studies had suggested that non-diabetic renal disease (NDRD) was common among non-insulin dependent diabetes mellitus (NIDDM) patients with involvement. METHODS: We prospectively studied the prevalence of NDRD a Chinese NIDDM population. Renal biopsy specimens were evaluated light-, immunohistological and electron-microscopy. The cohort consisted 51 who proteinuria > 1 g/24 h. RESULTS: Patients both isolated diabetic nephropathy (DN, n = 34) (n 17) comparable duration DM,...
Abstract There is limited information describing the characteristics and clinical outcomes of patients infected with coronavirus disease 2019 (COVID‐19) especially those in underserved urban area minority population United States. This a retrospective single‐center study for who were admitted COVID‐19 infection. Data collection was from 1 March through 24 April 2020. Demographic, clinical, laboratory, treatment data presented using descriptive statistics frequencies. The χ 2 test...
Coronavirus disease 19 (COVID-19) has become a pandemic. Diabetic patients tend to have poorer outcomes and more severe (Kumar et al. in Diabetes Metab Syndr 14(4):535-545, 2020. https://doi.org/10.1016/j.dsx.2020.04.044 ). However, the vast majority of studies are representative Asian Caucasian population fewer represent an African-American population.In this single-center, retrospective observational study, we included all adult (> 18 years old) admitted Einstein Medical Center,...
In critically ill patients with coronavirus disease 2019, there has been considerable debate about when to intubate acute respiratory failure. Early expert recommendations supported early intubation. However, as we learned more this disease, the risks versus benefits of intubation are less clear. We report our findings from an observational study aimed compare difference in outcomes 2019 who were intubated later course. need for was defined either at admission or within 2 days having a...
A lot remains unknown about the features and laboratory findings that may predict worse outcomes in patients with coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate difference complete blood count parameters differential counts hospitalized COVID-19 who survived compared those died.We performed a single-center retrospective including 242 confirmed COVID-19. We described characteristics these patients. Mann-Whitney U test used compare hematologic died survived;...
Recent studies have reported evidence that coronavirus disease 2019 (COVID-19) has disproportionately affected patients with underlying comorbidities. Our study aims to evaluate the impact of both cardiac and noncardiac comorbidities on a high-risk population COVID-19 infection coronary artery (CAD) compared those without CAD.This is retrospective who tested positive via reverse transcriptase-PCR (RT-PCR) assay. We characteristics outcomes CAD. Population demographics, clinical were...
Background: The novel coronavirus (SARS CoV-2) has caused significant morbidity and mortality in patients with diabetes. However, the effects of diabetes control including insulin use remain uncertain terms clinical outcomes COVID-19.